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Abstract
© 2016 Wiley Periodicals, Inc. 2,4,6-Trinitrotoluene (TNT) has been widely used as an explosive
substance and its toxicity is still of interest as it persisted in polluted areas. TNT is metabolized
in hepatocytes which are prone to its toxicity. Since analysis of the human liver or hepatocytes
is restricted due to ethical reasons, we investigated the effects of TNT on cell viability, reactive
oxygen  species  (ROS)  production,  peroxisome  proliferation,  and  antioxidative  enzymes  in
human (HepG2),  mouse  (Hepa 1-6),  and  rat  (H4IIEC3)  hepatoma cell  lines.  Under  control
conditions,  hepatoma cells  of  all  three species were highly comparable exhibiting identical
proliferation  rates  and  distribution  of  their  cell  cycle  phases.  However,  we  found  strong
differences in TNT toxicity with the lowest IC 50 values (highest cell death rate) for rat cells,
whereas human and mouse cells were three to sevenfold less sensitive. Moreover, a strong
decrease in cellular dehydrogenase activity (MTT assay) and increased ROS levels were noted.
TNT caused peroxisome proliferation with rat hepatoma cells being most responsive followed by
those from mouse and human. Under control conditions, rat cells contained fivefold higher
peroxisomal catalase and mitochondrial SOD2 activities and a twofold higher capacity to reduce
MTT than human and mouse cells. TNT treatment caused an increase in catalase and SOD2
mRNA and protein levels in human and mouse, but not in rat cells. Similarly, human and mouse
cells upregulated SOD2 activity, whereas rat cells failed therein. We conclude that TNT induced
oxidative stress, peroxisome proliferation and mitochondrial damage which are highest in rat
cells rendering them most susceptibl e toward TNT. © 2016 Wiley Periodicals, Inc. Environ
Toxicol 32: 989–1006, 2017.
http://dx.doi.org/10.1002/tox.22299
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